Rodrigo’s research in the field of nanotechnology and cell interaction led to an international patent for a novel broad-spectrum antibiotic effective against such pathogens as methicillin-resistant Staphylococcus aureus (MRSA), antibiotic resistant bacteria and fungus.

During his undergraduate studies, Rodrigo completed biotechnological research of proteins, enzymes, bacteria, and biodegradation of harmful compounds with the Institute of Biotechnology.